Electronic Health Record Strategies to Promote Diverse Participation in Research AIM 2

Yale University

Status: Completed

Conditions: Patient Participation

Treatments: Other: Direct to Patient Message - Optimized; Other: Optimized Letter; Other: Traditional Letter; Other: Direct to Patient Message

Study type: Interventional

Funder types: Other; Other U.S. Federal agency

Identifiers

NCT06467487

2000032716_a

75F40120C00174 (Other Grant/Funding Number)

Details and patient eligibility

About

Based on the outcomes of the initial study (NCT05348603), this optimization study will employ the most effective interventions (letters and messages) and distribute these communications to underrepresented minorities to further promote interest in research. Optimized language will be distributed in English, Spanish, Portuguese, Chinese, Arabic, or Haitian Creole, based on preferred language identified in the patient profile in an electronic medical records system.

Full description

The primary objective of the optimization study is to examine the effectiveness on increasing interest in research of an optimized letter versus a generic letter; an optimized message versus a generic message; and an optimized letter and an optimized message versus a generic letter and a generic message.

The secondary objective of the optimization study is to examine the effectiveness on increasing participation in research of an optimized letter versus a generic letter, an optimized message versus a generic message, an optimized letter and an optimized message versus a generic letter and a generic message.

Enrollment: 214,526 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Has an account with the online patient portal
• Has logged into the online patient portal at least once in the past year
• Has not set up a research profile

Exclusion criteria

• Currently enrolled in a clinical trial
• Opted out of research
• On active cancer treatment
• Active member of the study team

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

214,526 participants in 6 patient groups

Optimized Letter

Experimental group

Description:

Participants receive an 'optimized' letter.

Treatment:

Other: Optimized Letter

Optimized Message

Experimental group

Description:

Participants receive an 'optimized' message.

Treatment:

Other: Direct to Patient Message - Optimized

Optimized Letter + Optimized Message

Experimental group

Description:

Participants receive both a 'optimized' letter and a 'optimized' message.

Treatment:

Other: Direct to Patient Message - Optimized

Other: Optimized Letter

Generic Letter

Active Comparator group

Description:

Participants receive a 'usual' letter.

Treatment:

Other: Traditional Letter

Generic Message

Active Comparator group

Description:

Participants receive a 'usual' message.

Treatment:

Other: Direct to Patient Message

Generic Letter + Generic Message

Experimental group

Description:

Participants receive both a 'usual' letter and a 'usual' message.

Treatment:

Other: Direct to Patient Message

Other: Traditional Letter